Open Access Article
Francesc A.
Esteve-Turrillas
a,
Josep V.
Mercader
a,
Consuelo
Agulló
b,
Javier
Marzo
b,
Antonio
Abad-Somovilla
b and
Antonio
Abad-Fuentes
*a
aInstitute of Agrochemistry and Food Technology, Consejo Superior de Investigaciones Científicas (IATA-CSIC), Agustí Escardino 7, 46980 Paterna, València, Spain. E-mail: aabad@iata.csic.es
bDepartment of Organic Chemistry, Universitat de València, Doctor Moliner 50, 46100 Burjassot, València, Spain. E-mail: antonio.abad@uv.es
First published on 28th April 2014
Boscalid is a modern agrochemical belonging to the so-called chemical class of succinate dehydrogenase inhibitor fungicides. With the aim of developing rapid analytical screening methods for this relevant compound, we herein report the synthesis of new boscalid mimics and the study of their suitability for the production of polyclonal antibodies. Aliphatic spacer arms equivalent in length and composition were tethered at two different aromatic rings of the target molecular structure. These haptens, besides being used for immunization, were employed in the development of heterologous competitive enzyme-linked immunosorbent assays (cELISAs) in order to improve assay detectability. Direct and indirect immunoassays were tailored and applied to the determination of samples with incurred boscalid residues. The assays were characterized in terms of sensitivity, specificity, trueness, and precision. Limit of quantification was established at 5 μg kg−1, coefficients of variation were lower than 20%, and recoveries from spiked samples ranged from 90 to 137%. Finally, ELISA performance was evaluated by Deming regression analysis with tomato and cucumber samples, selecting ultra-performance liquid chromatography-mass spectrometry as the reference method. The results showed that the proposed cELISAs are useful for the routine determination of boscalid fungicides in foods with high-sample throughput and affordable cost.
The use of alternative methodologies such as immunochemical techniques is currently deemed as an excellent analytical option, in particular when a limited number of targets are sought.10,11 The most extended immunochemical approach for the determination of low molecular weight analytes is based on competitive enzyme-linked immunosorbent assays (cELISAs) because this assay format is simple, affordable, and reliable. Additionally, cELISAs allow the sensitive and simultaneous analysis of numerous samples, commonly they require a simplified sample treatment, and allow on-site use. The first reported approach for the production of antibodies against boscalid was recently published by our group.12 In that previous study, immunoreagents were produced using hapten BLa (see Fig. 1), which contained a five-carbon atom spacer arm linked to the pyridine ring through a sulphur atom which replaced the chlorine atom present in the boscalid structure. It is well-known that antibody affinity and selectivity may be strongly influenced by the design of the immunizing hapten.13 Therefore, although previous antibodies derived from hapten BLa displayed convenient analytical features, we wondered whether other possible tethering sites may give rise to antibodies of superior performance. Furthermore, the availability of different haptens and conjugates paves the way to develop heterologous cELISAs, a well-known approach to increase assay sensitivity in which the competitive reaction is driven by a protein conjugate carrying a hapten different to that employed in the immunogen.14–17 In the present study, two novel haptens (BLb and BLc, Fig. 1) with alternative linker attachment sites have been synthesized and employed in the preparation of protein conjugates and in the production of polyclonal antibodies to boscalid. A comprehensive evaluation of the generated immunoreagents has been carried out in order to develop cELISAs of high sensitivity. Finally, two new immunoassays, using direct and indirect cELISA formats, have been applied to the determination of boscalid residues in foods.
Horseradish peroxidase (HRP), ovalbumin (OVA), o-phenylenediamine (OPD), and triphenyl phosphate (TPP) were purchased from Sigma-Aldrich (Madrid, Spain). Sephadex G-25 HiTrap Desalting columns from GE Healthcare (Uppsala, Sweden) were used for conjugate purification. Goat anti-rabbit immunoglobulin polyclonal antibody–peroxidase conjugate (GAR–HRP) was purchased from Biorad (Hercules, CA, USA). Bovine serum albumin (BSA) fraction V was purchased from Roche Applied Science (Mannheim, Germany). Foetal bovine serum (FBS) and Freund's adjuvants were purchased from Sigma-Aldrich (Madrid, Spain). Costar flat-bottom high-binding polystyrene ELISA plates were purchased from Corning (Corning, NY, USA). Ultraviolet-visible spectra and ELISA absorbances were read with a PowerWave HT from BioTek Instruments (Winooski, VT, USA). ELISA plates were washed with an ELx405 microplate washer also from BioTek Instruments. A T-25 ultra-turrax blender and a Vortex mixer Ms2 were purchased from IKA (Staufen, Germany), and an Eppendorf 5804 centrifuge (Hamburg, Germany) was employed for the extraction of vegetables. PSA was obtained from Varian (Lake Forest, CA, USA).
The composition, concentration and pH of the employed buffers were as follows: (i) PB, 100 mM sodium phosphate buffer (pH 7.4); (ii) PBS, 10 mM sodium phosphate buffer (pH 7.4) with 140 mM NaCl; (iii) PBST, PBS containing 0.05% (v/v) Tween 20; (iv) CB, 50 mM carbonate–bicarbonate buffer (pH 9.6); (v) washing solution, 150 mM NaCl and 0.05% (v/v) Tween 20; (vi) enzyme substrate buffer, 25 mM citrate and 62 mM sodium phosphate buffer (pH 5.4); and (vii) PBST (2×), 20 mM sodium phosphate buffer (pH 7.4) with 280 mM NaCl and 0.05% (v/v) Tween 20.
:
MeOH 9
:
1 as an eluent). The reaction mixture was diluted with CHCl3, washed with a 10% aqueous solution of NaHCO3 and brine, and dried over anhydrous Na2SO4. The residue obtained after evaporation of the solvent was purified by column chromatography, using CHCl3 as an eluent, affording the nearly pure NHS esters as determined by 1H NMR spectra (copies of original spectra are included in the ESI†).
BLb-NHS ester: (86% yield). 1H-NMR (300 MHz, CDCl3) δ (ppm) 8.71 (1H, d, J = 8.4 Hz, H-5 PhPh), 8.11 (1H, s, NH), 7.81 (1H, dd, J = 4.7, 2.0 Hz, H-6 Py), 7.77 (1H, dd, J = 7.7, 2.0 Hz, H-4 Py), 7.11–6.85 (6H, m, H-2′/H-6′, H-3′/H-5′, H-2 and H-4 PhPh), 6.33 (1H, dd, J = 7.7, 4.7 Hz, H-5 Py), 2.36 (2H, t, J = 7.6 Hz, H-6), 2.15 (2H, t, J = 7.3 Hz, H-2), 1.77–1.51 (4H, m, COCH2CH2CO), 1.45–1.28 (4H, m, H-3 and H-5), 1.22–1.08 (2H, m, H-4).
BLc-NHS ester: (70% yield). 1H-NMR (300 MHz, C6D6) δ (ppm) d 8.47–8.44 (2H, m, H-3′ PhPh and H-6 Py), 8.22 (1H, br s, NH), 8.13 (1H, dd, J = 7.7, 1.9 Hz, H-4 Py), 7.48–7.42 (8H, m, H-2/H-6, H-3/H-5, H-4′, H-5′, H-6′ PhPh and H-5 Py), 2.99 (2H, t, J = 7.0 Hz, H-5), 2.83 (4H, br s, COCH2CH2CO), 2.66 (2H, t, J = 7.2 Hz, H-2), 1.75–1.90 (4H, m, H-3 and H-4).
:
1 mixture of PB and complete Freund's adjuvant. Animals were boosted at 21-day intervals with the same amount of immunogen suspended in a mixture of 0.5 mL of PB and 0.5 mL of incomplete Freund's adjuvant. Whole blood was collected by intracardiac puncture 10 days after the fourth injection. Blood samples were allowed to coagulate overnight at 4 °C. Then, the serum was separated by centrifugation (3000× g, 20 min) and precipitated by adding 1 volume of a saturated aqueous solution of ammonium sulphate. This procedure was repeated again and the precipitates were finally stored at 4 °C.
The QuEChERS method has been widely employed for the extraction and purification of fungicide residues from fruits and vegetables.4 In our case, 5 mL of chopped sample, plus 50 μL internal standard (TPP at 50 mg L−1), were introduced in a 50 mL polypropylene centrifuge tube containing 0.5 g sodium acetate and 2 g anhydrous magnesium sulphate. Samples were then extracted with 5 mL of 1% (v/v) acetic acid in acetonitrile by vortexing for 1 min and centrifuged for 5 min at 2200× g. Then, 1 mL extract was introduced into a 2 mL polypropylene centrifuge tube containing 50 mg PSA and 150 mg anhydrous magnesium sulphate, vortexed for 1 min, and centrifuged for 5 min at 2200× g. Finally, the purified extract was filtered through a 0.22 μm Teflon filter and analyzed by the proposed direct and indirect cELISAs, as well as by the reference chromatographic method.
Following this strategy, the synthesis of hapten BLb required the preparation of the synthon corresponding to the biphenyl moiety, compound 8. As outlined in Scheme 1, the synthesis of compound 8 started from 2,4-diiodo-1-nitrobenzene (2), easily available from 1,3-diiodobenzene (1),23 and is based on the different reactivity of the two iodinated positions against palladium catalyzed cross-coupling processes. First, the spacer arm was introduced at the appropriate position of the aromatic ring subunit by means of a regioselective Sonogashira coupling with tert-butyl hex-5-ynoate (3), which was followed by a Suzuki–Miyaura cross-coupling reaction with 4-chlorophenylboronic acid (5) to form the biphenyl derivative 6. Hydrogenation of the acetylenic triple bond using Wilkinson's catalyst followed by reduction of the nitro group with iron completed the preparation of the biphenyl amine 8, from which the synthesis of hapten BLb was readily accomplished via coupling with 2-chloronicotinoyl chloride (9) and subsequent acid-catalyzed hydrolysis of the tert-butyl ester moiety.
The synthesis of hapten BLc required the preparation of the 2-aminobiphenyl intermediate 17 (Scheme 2). Its synthesis started from 4-mercaptophenylboronic acid (11) that was initially transformed into the corresponding ethylene glycol ester 12 in order to avoid interference of the boronic acid moiety in the subsequent alkylation reaction of the mercaptide group. Further alkylation of 12 with tert-butyl 5-bromopentanoate (13) followed by chromatography on a silica gel, which induced the hydrolysis of the ethylene glycol ester moiety, led to the formation of boronic acid 14. Completion of the synthesis of 17 was efficiently accomplished by means of a Suzuki–Miyaura cross-coupling reaction followed by reduction of the nitro group. The last steps for the preparation of hapten BLc were straightforward, involving the formation of the amide linkage by the reaction between 17 and 2-chloronicotinoyl chloride (9) followed by formic acid catalyzed hydrolysis of the tert-butyl ester moiety.
For direct cELISA, plates were coated with 1/6 × 104 and 1/3 × 104 dilutions of the antiserum, and the next day, a range of enzyme tracer concentrations (from 1 to 300 μg L−1) was evaluated under competitive conditions. For heterologous combinations lower antiserum dilutions (1/3 × 103 and 1/104) were used because of the poorer recognition of heterologous conjugates. A collection of inhibition curves was so obtained for each pair of immunoreagents, and a summary of the parameters (Amax, slope, and IC50 values) of the inhibition curves resulting from the more adequate concentrations is shown in Table 1. Homologous assays showed IC50 values in the 0.4–1.6 μg L−1 range, depending on the employed antisera. The use of heterologous conjugates improved the sensitivity of the assays, as illustrated by mixed combinations of BLa- and BLb-derived immunoreagents. However, in the case of antibodies BLc#1 and BLc#2, IC50 values hardly improved by using tracers HRP–BLa or HRP–BLb. Finally, the assay with antiserum BLb#2 and tracer HRP–BLa brought about the most sensitive direct assay (IC50 = 0.2 μg L−1).
| Antibody | Direct assay | Indirect assay | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antibody dilution | HRP tracer (μg L−1) | A max | Slope | IC50 (μg L−1) | Antibody dilution | OVA coating (mg L−1) | A max | Slope | IC50 (μg L−1) | |||||
| BLa | BLb | BLc | BLa | BLb | BLc | |||||||||
| a For each combination of immunoreagents, the particular concentrations in the table are those resulting in the lowest IC50 value provided that Amax was higher than 0.6. IC50 values from homologous combinations are indicated in bold. | ||||||||||||||
| BLa#1 | 6 × 104 | 3 | — | — | 0.79 | 0.52 | 0.4 | 3 × 105 | 0.1 | — | — | 1.05 | 0.67 | 0.9 |
| 104 | — | 30 | — | 0.61 | 0.99 | 0.3 | 104 | — | 0.1 | — | 0.73 | 0.89 | 0.2 | |
| 104 | — | — | 10 | 1.04 | 0.76 | 1.0 | 105 | — | — | 0.1 | 1.21 | 0.73 | 1.1 | |
| BLa#2 | 6 × 104 | 3 | — | — | 1.00 | 0.61 | 1.6 | 106 | 0.1 | — | — | 0.97 | 0.55 | 0.9 |
| 104 | — | 10 | — | 1.50 | 1.48 | 0.9 | 105 | — | 1 | — | 0.96 | 0.52 | 0.5 | |
| 104 | — | — | 10 | 1.39 | 0.84 | 1.7 | 3 × 105 | — | — | 0.1 | 0.78 | 0.71 | 1.7 | |
| BLb#1 | 104 | 30 | — | — | 0.96 | 0.96 | 0.5 | 3 × 104 | 0.1 | — | — | 0.73 | 1.07 | 0.4 |
| 6 × 104 | — | 3 | — | 0.73 | 0.66 | 0.6 | 3 × 105 | — | 0.1 | — | 1.11 | 0.62 | 0.3 | |
| 104 | — | — | 10 | 0.92 | 0.78 | 0.9 | 105 | — | — | 0.1 | 0.71 | 0.65 | 0.3 | |
| BLb#2 | 3 × 103 | 30 | — | — | 0.70 | 0.84 | 0.2 | 3 × 104 | 0.1 | — | — | 0.74 | 1.09 | 0.1 |
| 3 × 104 | — | 3 | — | 1.25 | 0.54 | 1.2 | 3 × 104 | — | 0.01 | — | 1.18 | 0.75 | 0.4 | |
| 104 | — | — | 10 | 1.52 | 0.82 | 0.5 | 105 | — | — | 0.1 | 0.88 | 0.81 | 0.5 | |
| BLc#1 | 104 | 10 | — | — | 1.25 | 0.94 | 0.9 | 105 | 0.1 | — | — | 1.06 | 0.83 | 0.4 |
| 104 | — | 10 | — | 1.20 | 1.05 | 1.6 | 3 × 104 | — | 0.1 | — | 0.76 | 0.76 | 0.8 | |
| 6 × 104 | — | — | 3 | 1.17 | 0.54 | 0.8 | 105 | — | — | 0.01 | 1.36 | 0.76 | 0.9 | |
| BLc#2 | 3 × 103 | 10 | — | — | 0.90 | 0.68 | 1.9 | 3 × 104 | 0.1 | — | — | 1.05 | 0.70 | 5.1 |
| 104 | — | 100 | — | 0.77 | 0.75 | 6.7 | 104 | — | 0.1 | — | 0.81 | 1.12 | 1.1 | |
| 6 × 104 | — | — | 3 | 1.25 | 0.76 | 1.6 | 105 | — | — | 0.01 | 1.14 | 0.76 | 1.7 | |
For indirect cELISA, plates were coated with 0.01 and 0.1 mg L−1 OVA conjugate solutions, and the competitive step was carried out using a range of antisera dilutions (from 1/104 to 1/106). Indirect assays also showed a low recognition of heterologous conjugates, so a higher coating concentration was assessed (1.0 mg L−1). Table 1 shows the main parameters from the inhibition curves of the more sensitive combinations. IC50 values obtained for homologous assays ranged from 0.3 to 1.7 μg L−1, and sensitivity improvements were again noticed by using heterologous conjugates. Antiserum BLb#2 in combination with the coating conjugate OVA–BLa resulted in an assay of remarkable sensitivity (IC50 = 0.1 μg L−1).
| cELISA | ||
|---|---|---|
| Format | Direct (●) | Indirect (○) |
| a Values are the mean of 8 independent experiments. b LOD was estimated as the boscalid concentration causing a 10% inhibition of Amax. | ||
| Antibody | BLb#2 (1/3 × 103) | BLb#2 (1/2 × 104) |
| Conjugate | HRP–BLa (40 μg L−1) | OVA–BLa (100 μg L−1) |
| A max | 1.73 ± 0.09 | 1.14 ± 0.18 |
| A min | 0.051 ± 0.007 | 0.055 ± 0.016 |
| Slope | −1.34 ± 0.11 | −1.04 ± 0.03 |
| IC50 (μg L−1) | 0.22 ± 0.02 | 0.26 ± 0.05 |
| LODb (μg L−1) | 0.05 | 0.03 |
![]() | ||
| Fig. 2 Variation of Amax and IC50 values of the proposed direct (A) and indirect (B) cELISAs as a function of the presence of organic solvents. | ||
Secondly, recovery studies were performed using analyte-free samples spiked with boscalid at different concentrations (5, 10, 50, 100, 500, 1000, and 5000 μg kg−1). Fortified samples were homogenized by vortex mixing, extracted by QuEChERS, and measured by the proposed cELISAs after being diluted 1/100 (low-level spiked samples) and 1/1000 (high-level spiked samples) with buffer. As shown in Table 3, adequate recovery values were obtained for all the evaluated concentrations. Concerning precision, relative standard deviation (RSD) values were lower than 20%. Accordingly, the limit of quantification (LOQ), defined as the minimal concentration that can be measured with satisfactory accuracy (recoveries between 80 and 120%) and precision (RSD lower than 20%), was established at 5 μg kg−1 for the indirect assay and at 10 μg kg−1 for the direct assay.
| Assay format | [Boscalid]b (μg kg−1) | Recovery (% ± s, n = 5) | |
|---|---|---|---|
| Tomato | Cucumber | ||
| a Samples spiked at 5–50 μg kg−1 were diluted in assay buffer 1/100, whereas samples spiked at 100–500 μg kg−1 were diluted 1/1000. b Boscalid concentration in μg kg−1. | |||
| Direct | 5 | 128 ± 9 | 137 ± 27 |
| 10 | 113 ± 17 | 113 ± 8 | |
| 50 | 99 ± 7 | 102 ± 7 | |
| 100 | 97 ± 7 | 99 ± 8 | |
| 500 | 91 ± 15 | 92 ± 14 | |
| 1000 | 94 ± 14 | 97 ± 4 | |
| 5000 | 96 ± 7 | 90 ± 5 | |
| Indirect | 5 | 97 ± 8 | 103 ± 8 |
| 10 | 108 ± 5 | 98 ± 10 | |
| 50 | 96 ± 8 | 94 ± 12 | |
| 100 | 99 ± 3 | 101 ± 15 | |
| 500 | 96 ± 11 | 102 ± 6 | |
| 1000 | 99 ± 10 | 97 ± 9 | |
| 5000 | 97 ± 3 | 107 ± 18 | |
Finally, samples from in-field treated crops were analysed by the developed immunochemical methods and by UPLC-MS-MS as a reference procedure. Table 4 shows that boscalid concentrations in these samples ranged from 230 to 510 μg kg−1, well-below the EU maximum residue limit for cucumbers and tomatoes (3 mg kg−1). In order to get a larger number of positive samples covering a wide range of boscalid concentrations, blind spiked samples were prepared enabling a more comprehensive validation of the immunoassays. A total of 16 samples were fortified by an external operator and analysed by the three analytical methodologies, the two proposed cELISAs and UPLC-MS-MS (Table 4). Boscalid concentrations ranged from 150 to 2600 μg kg−1. Deming regression analysis was employed for data comparison, and Fig. 3 shows the obtained regression graphs and the 95% confidence interval (CI) bands for direct and indirect cELISAs versus UPLC-MS-MS.
| Sample | Name | [Boscalid] (μg kg−1 ± s, n = 3) | ||
|---|---|---|---|---|
| UPLC-MS-MS | Direct cELISA | Indirect cELISA | ||
| In-field treated | T1 | 510 ± 50 | 440 ± 30 | 490 ± 40 |
| T2 | 420 ± 50 | 420 ± 40 | 420 ± 60 | |
| T3 | 230 ± 20 | 230 ± 20 | 230 ± 30 | |
| T4 | 260 ± 20 | 235 ± 8 | 240 ± 10 | |
| C1 | 250 ± 40 | 350 ± 20 | 350 ± 60 | |
| C2 | 460 ± 30 | 400 ± 30 | 440 ± 30 | |
| C3 | 230 ± 30 | 450 ± 20 | 490 ± 30 | |
| C4 | 260 ± 40 | 430 ± 30 | 450 ± 50 | |
| Blind spiked | T5 | 150 ± 20 | 140 ± 10 | 130 ± 20 |
| T6 | 270 ± 30 | 260 ± 10 | 260 ± 10 | |
| T7 | 400 ± 30 | 390 ± 10 | 400 ± 20 | |
| T8 | 870 ± 90 | 780 ± 30 | 760 ± 20 | |
| T9 | 1400 ± 100 | 1270 ± 60 | 1250 ± 40 | |
| T10 | 1600 ± 200 | 1570 ± 30 | 1500 ± 100 | |
| T11 | 1900 ± 200 | 1810 ± 90 | 1860 ± 80 | |
| T12 | 2400 ± 200 | 2090 ± 80 | 2500 ± 100 | |
| C5 | 210 ± 10 | 200 ± 20 | 210 ± 10 | |
| C6 | 310 ± 30 | 290 ± 20 | 300 ± 10 | |
| C7 | 600 ± 80 | 440 ± 20 | 550 ± 40 | |
| C8 | 960 ± 90 | 940 ± 80 | 940 ± 80 | |
| C9 | 1300 ± 100 | 1300 ± 70 | 1300 ± 100 | |
| C10 | 1900 ± 200 | 1700 ± 100 | 1790 ± 50 | |
| C11 | 2000 ± 200 | 1700 ± 100 | 1870 ± 20 | |
| C12 | 2600 ± 200 | 2100 ± 100 | 2560 ± 30 | |
![]() | ||
| Fig. 3 Deming regression analysis of direct (A) and indirect (B) cELISAs vs. UPLC-MS-MS with tomato and cucumber samples. | ||
Comparison of the direct assay with UPLC-MS-MS produced a Deming regression slope of 0.93 (CI from 0.85 to 1.01) and an intercept of 21 (CI from −9 to 52); and for the indirect assay the slope was 0.98 (CI from 0.90 to 1.05) and the intercept was 9 (CI from −20 to 38). Therefore, both Deming fittings have slopes and intercepts statistically equal to 1 and 0, respectively; it could therefore be concluded that the developed cELISAs provided results statistically comparable to the reference method.
Footnote |
| † Electronic supplementary information (ESI) available: Additional chemicals and instruments, experimental details of hapten synthesis, and spectrometric characterization data for the synthesized compounds. See DOI: 10.1039/c3an01104f |
| This journal is © The Royal Society of Chemistry 2014 |